Zobrazeno 1 - 10
of 169
pro vyhledávání: '"DG Charteris"'
Autor:
Karen Eastlake, Peng T. Khaw, Gillian J. McLellan, Hari Jayaram, Robert A. Brown, Megan F. Jones, G. Astrid Limb, Silke Becker, DG Charteris
Publikováno v:
Stem Cells Translational Medicine
This study investigated the effect of allogeneic transplantation of feline Müller glia with the ability to differentiate into cells expressing retinal ganglion cell (RGC) markers, following ablation of RGCs by N-methyl-d-aspartate. The results sugge
Publikováno v:
Glia. 64:495-506
Retinal gliosis is characterized by biochemical and physiological changes that often lead to Muller glia proliferation and hypertrophy and is a feature of many neuro-degenerative and inflammatory diseases such as proliferative vitreoretinopathy (PVR)
Autor:
JF Cullen, DG Charteris
Publikováno v:
Journal of Neuro-Ophthalmology. 16:110-114
Two cases of radiologically proven primary empty sella syndrome with binasal field defects are described. The association of these two entities is discussed.
Autor:
Leon G D'Cruz, G. Astrid Limb, Gavin Arno, DG Charteris, Aman Chandra, Anne H. Child, Jose Antonio Aragon-Martin
Publikováno v:
Experimental eye research. 104
The ADAMTSL4 gene (MIM:610113) is a member of the ADAMTSL (A Disintegrin AndMetalloproteinase with Thrombospondin Motifs Like) gene family. It is found on chromosome 1q21 and encodes the 1074 amino acid ADAMTS-Like 4 protein (NP_061905). ADAMTSL4 con
A 38-year-old man who died from systemic Behcet's disease had previously suffered from severe, recurrent bilateral retinal vasculitis, and anterior uveitis for 10 years. Immunopathological examination of the eyes postmortem revealed marked hyaline th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b356d383282a4d64c68e368fa733091b
https://europepmc.org/articles/PMC504327/
https://europepmc.org/articles/PMC504327/
Autor:
Anguita R; Moorfields Eye Hospital NHS Foundation Trust, London, UK. rodrigoanguita@gmail.com.; Department of Ophthalmology, Inselspital, University Hospital of Bern, Bern, Switzerland. rodrigoanguita@gmail.com., Roth J; Moorfields Eye Hospital NHS Foundation Trust, London, UK.; Department of Ophthalmology, Inselspital, University Hospital of Bern, Bern, Switzerland., Ferro Desideri L; Department of Ophthalmology, Inselspital, University Hospital of Bern, Bern, Switzerland., Makuloluwa A; Moorfields Eye Hospital NHS Foundation Trust, London, UK., Katta M; Moorfields Eye Hospital NHS Foundation Trust, London, UK., Shahid S; Moorfields Eye Hospital NHS Foundation Trust, London, UK., Olvera-Barrios A; Moorfields Eye Hospital NHS Foundation Trust, London, UK., Charteris DG; Moorfields Eye Hospital NHS Foundation Trust, London, UK.
Publikováno v:
Eye (London, England) [Eye (Lond)] 2024 Dec; Vol. 38 (17), pp. 3285-3289. Date of Electronic Publication: 2024 Jul 28.
Autor:
Bourkiza R; Department of Vitreoretinal Surgery, Moorfields Eye Hospital, 162 City Road, London, EC1V 2PD, UK., Vakros G; Department of Vitreoretinal Surgery, Moorfields Eye Hospital, 162 City Road, London, EC1V 2PD, UK. g.vakros@nhs.net., Tarafdar S; Department of Ophthalmology, Ninewells hospital, James Arrott drive, Dundee, DD2 1SG, UK., Yang E; Department of Vitreoretinal Surgery, Moorfields Eye Hospital, 162 City Road, London, EC1V 2PD, UK., Charteris DG; Department of Vitreoretinal Surgery, Moorfields Eye Hospital, 162 City Road, London, EC1V 2PD, UK.; NIHR Biomedical Research Centre at Moorfields Eye Hospital and University College London Institute of Ophthalmology, London, EC1V 2PD, UK.
Publikováno v:
Eye (London, England) [Eye (Lond)] 2024 Jun; Vol. 38 (9), pp. 1642-1646. Date of Electronic Publication: 2024 Feb 23.
Autor:
Anguita R; Vitreoretinal Unit, Moorfields Eye Hospital NHS Foundation Trust, City Road, London, EC1V 2PD, UK. rodrigoanguita@gmail.com.; Ocular Oncology Service, Moorfields Eye Hospital NHS Foundation Trust, City Road, London, EC1V 2PD, UK. rodrigoanguita@gmail.com.; Department of Ophthalmology, Inselspital, University Hospital of Bern, Bern, Switzerland. rodrigoanguita@gmail.com., Makuloluwa A; Vitreoretinal Unit, Moorfields Eye Hospital NHS Foundation Trust, City Road, London, EC1V 2PD, UK., Bhalla M; Vitreoretinal Unit, Moorfields Eye Hospital NHS Foundation Trust, City Road, London, EC1V 2PD, UK., Katta M; Vitreoretinal Unit, Moorfields Eye Hospital NHS Foundation Trust, City Road, London, EC1V 2PD, UK., Sagoo MS; Ocular Oncology Service, Moorfields Eye Hospital NHS Foundation Trust, City Road, London, EC1V 2PD, UK.; NIHR Biomedical Research Centre for Ophthalmology at UCL Institute of Ophthalmology and Moorfields Eye Hospital, London, EC1V 2PD, UK., Charteris DG; Vitreoretinal Unit, Moorfields Eye Hospital NHS Foundation Trust, City Road, London, EC1V 2PD, UK.; NIHR Biomedical Research Centre for Ophthalmology at UCL Institute of Ophthalmology and Moorfields Eye Hospital, London, EC1V 2PD, UK.
Publikováno v:
Eye (London, England) [Eye (Lond)] 2024 Feb; Vol. 38 (3), pp. 494-498. Date of Electronic Publication: 2023 Aug 18.